1. Home
  2. AMR vs GPCR Comparison

AMR vs GPCR Comparison

Compare AMR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Metallurgical Resources Inc.

AMR

Alpha Metallurgical Resources Inc.

HOLD

Current Price

$201.15

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$42.97

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMR
GPCR
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
AMR
GPCR
Price
$201.15
$42.97
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$181.50
$103.17
AVG Volume (30 Days)
234.7K
702.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,129,481,000.00
N/A
Revenue This Year
$15.05
N/A
Revenue Next Year
$14.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$104.42
$15.80
52 Week High
$253.82
$94.90

Technical Indicators

Market Signals
Indicator
AMR
GPCR
Relative Strength Index (RSI) 52.73 58.04
Support Level $198.13 $42.72
Resistance Level $212.15 $57.23
Average True Range (ATR) 13.44 2.11
MACD -0.77 0.93
Stochastic Oscillator 51.76 92.13

Price Performance

Historical Comparison
AMR
GPCR

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: